Efficacy and Safety of TD-1473 in Crohn's Disease

NCT03635112 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
167
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated by the sponsor on 16 November 2021 after a planned review by the Independent Data Monitoring Committee.

Conditions

Interventions

Sponsor

Theravance Biopharma